Skip to main content

Advertisement

Log in

Xanthohumol improves cognitive impairment by regulating miRNA-532-3p/Mpped1 in ovariectomized mice

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Studies have shown the potential neuroprotective effect of xanthohumol, while whether xanthohumol has the ability of repairing cognitive impairment and its underlying mechanism still remains obscure.

Objectives

To unravel the mechanism of xanthohumol repairing cognitive impairment caused by estrogen deprivation.

Methods

C57BL/6 J female mice that underwent bilateral ovariectomy to establish cognitive decline model were randomly divided into three xanthohumol-treated groups and a saline-treated model group. For identifying the neuroprotective function of xanthohumol, Morris water maze (MWM) test and open field test (OFT) were conducted. After extracting total RNA of mouse hippocampus of different groups, mRNA-seq and microRNA (miRNA)-seq analysis were performed, and the differentially expressed miRNAs (DEMIs) and their target genes were further validated by qPCR. MiR-532-3p and its downstream gene Mpped1 were screened as targets of xanthohumol. Influence of miR-532-3p/Mpped1 to cognitive ability was examined via MWM test and OFT after stereotactic brain injection of Mpped1 overexpressed adeno-associated virus. The regulation of miR-532-3p on Mpped1 was confirmed in hippocampal neuronal cell line HT22 by luciferase reporter gene assay.

Results

Xanthohumol treatment reversed the cognitive decline of OVX mice according to behavioral tests. By comparing miRNA levels of xanthohumol-treated groups with saline-treated group, we found that the main changed miRNAs were miR-122-5p, miR-532-3p, and miR-539-3p. Increased miR-532-3p in OVX mice was suppressed by xanthohumol treatment. Furthermore, the downstream gene of miR-532-3p, Mpped1, was also increased by xanthohumol and showed the capability of relieving cognitive impairment of OVX mice after overexpressed in hippocampus. The 3′ untranslated region of Mpped1 was identified as the target region of miR-532-3p, and agomiR-532-3p remarkably reduced the expression of Mpped1 mRNA.

Conclusions

Xanthohumol has the ability of repairing cognitive impairment through removing the inhibition of miR-532-3p on Mpped1 in mouse hippocampus. This finding not only advances the understanding of neuroprotective mechanism of xanthohumol, but also provides novel treatment targets for dementia of postmenopausal women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data Availability

All data obtained during the current study are available from the corresponding author on reasonable request.

References

  • Abuelezz NZ, Nasr FE, AbdulKader MA, Bassiouny AR, Zaky A (2021) MicroRNAs as potential orchestrators of Alzheimer’s disease-related pathologies: insights on current status and future possibilities. Front Aging Neurosci 13:743573

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Adu-Nti F, Gao X, Wu JM, Li J, Iqbal J, Ahmad R, Ma XM (2021) Osthole ameliorates estrogen deficiency-induced cognitive impairment in female mice. Front Pharmacol 12:641909

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bailey ME, Wang AC, Hao J, Janssen WG, Hara Y, Dumitriu D, Hof PR, Morrison JH (2011) Interactive effects of age and estrogen on cortical neurons: implications for cognitive aging. Neuroscience 191:148–158

    Article  CAS  PubMed  Google Scholar 

  • Barbato C, Giacovazzo G, Albiero F, Scardigli R, Scopa C, Ciotti MT, Strimpakos G, Coccurello R, Ruberti F (2020) Cognitive decline and modulation of Alzheimer’s disease-related genes after inhibition of microRNA-101 in mouse hippocampal neurons. Mol Neurobiol 57:3183–3194

    Article  CAS  PubMed  Google Scholar 

  • Benameur T, Soleti R, Porro C (2021) The potential neuroprotective role of free and encapsulated quercetin mediated by miRNA against neurological diseases. Nutrients 13:1318

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Costa R, Rodrigues I, Guardao L, Rocha-Rodrigues S, Silva C, Magalhaes J, Ferreira-de-Almeida M, Negrao R, Soares R (2017) Xanthohumol and 8-prenylnaringenin ameliorate diabetic-related metabolic dysfunctions in mice. J Nutr Biochem 45:39–47

    Article  CAS  PubMed  Google Scholar 

  • Dweep H, Gretz N, Sticht C (2014) miRWalk database for miRNA-target interactions. Methods Mol Biol 1182:289–305

    Article  PubMed  Google Scholar 

  • Fang M, Wang J, Zhang X, Geng Y, Hu Z, Rudd JA, Ling S, Chen W, Han S (2012) The miR-124 regulates the expression of BACE1/beta-secretase correlated with cell death in Alzheimer’s disease. Toxicol Lett 209:94–105

    Article  CAS  PubMed  Google Scholar 

  • Fu WT, Chen LF, Wang Z, Zhao CW, Chen GZ, Liu X, Dai YR, Cai YP, Li CL, Zhou JM, Liang G (2016) Determination of the binding mode for anti-inflammatory natural product xanthohumol with myeloid differentiation protein 2. Drug Des Dev Ther 10:455–463

    CAS  Google Scholar 

  • Harish V, Haque E, Smiech M, Taniguchi H, Jamieson S, Tewari D, Bishayee A (2021) Xanthohumol for human malignancies: chemistry, pharmacokinetics and molecular targets. Int J Mol Sci 22:4478

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hart DA (2022) Sex differences in biological systems and the conundrum of menopause: potential commonalities in post-menopausal disease mechanisms. Int J Mol Sci 23:4119

    Article  PubMed  PubMed Central  Google Scholar 

  • Hebert SS, Horre K, Nicolai L, Papadopoulou AS, Mandemakers W, Silahtaroglu AN, Kauppinen S, Delacourte A, De Strooper B (2008) Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer’s disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci USA 105:6415–6420

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Henderson VW, Lobo RA (2012) Hormone therapy and the risk of stroke: perspectives 10 years after the Women’s Health Initiative trials. Climacteric 15:229–234

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Huang XF, Wang J, Chen X, Liu P, Wang SJ, Song FC, Zhang ZJ, Zhu FQ, Huang XF, Liu JJ, Song GQ, Spencer PS, Yang XF (2018) The prenylflavonoid xanthohumol reduces Alzheimer-like changes and modulates multiple pathogenic molecular pathways in the neuro2a/APP(swe) cell model of AD. Front Pharmacol 9:199

    Article  PubMed  PubMed Central  Google Scholar 

  • Jiao Y, Cao Y, Lu X, Wang J, Saitgareeva A, Kong X, Song C, Li J, Tian K, Zhang S, Bai M, Li S, Zhang H, Wang L (2020) Xanthohumol protects neuron from cerebral ischemia injury in experimental stroke. Mol Biol Rep 47:2417–2425

    Article  CAS  PubMed  Google Scholar 

  • Khan I, Preeti K, Fernandes V, Khatri DK, Singh SB (2021) Role of microRNAs, aptamers in neuroinflammation and neurodegenerative disorders. Cell Mol Neurobiol 42:2075–2095

    Article  PubMed  Google Scholar 

  • KnezHrnčič M, Španinger E, Košir IJ, Knez Ž, Bren U (2019) Hop compounds: extraction techniques, chemical analyses, antioxidative, antimicrobial, and anticarcinogenic effects. Nutrients 11:257

    Article  Google Scholar 

  • Kridawati A, Sulaeman A, Damanik R, Winarto A, Rahardjo TB, Hogervorst E (2016) Tempereversed effects of ovariectomy on brain function in rats: Effects of age and type of soy product. J Steroid Biochem Mol Biol 160:37–42

    Article  CAS  PubMed  Google Scholar 

  • Lai QX, Kovzel N, Konovalov R, Vinnikov IA (2021) MicroRNAs regulating autophagy in neurodegeneration. Autophagy: Biol Dis: Technol Methodol 1208:191–264

    Article  Google Scholar 

  • Lv HM, Liu QM, Wen ZM, Feng HH, Deng XM, Ci XX (2017) Xanthohumol ameliorates lipopolysaccharide (LPS)-induced acute lung injury via induction of AMPK/GSK3 beta-Nrf2 signal axis. Redox Biol 12:311–324

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Markowska AL, Savonenko AV (2002) Protective effect of practice on cognition during aging: implications for predictive characteristics of performance and efficacy of practice. Neurobiol Learn Mem 78:294–320

    Article  PubMed  Google Scholar 

  • Morgunova A, Flores C (2021) MicroRNA regulation of prefrontal cortex development and psychiatric risk in adolescence. Semin Cell Dev Biol 118:83–91

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nelson PT, Wang WX (2010) MiR-107 is reduced in Alzheimer’s disease brain neocortex: validation study. J Alzheimers Dis 21:75–79

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Peluso MR, Miranda CL, Hobbs DJ, Proteau RR, Stevens JF (2010) Xanthohumol and related prenylated flavonoids inhibit inflammatory cytokine production in LPS-activated THP-1 monocytes: structure-activity relationships and in silico binding to myeloid differentiation protein-2 (MD-2). Planta Med 76:1536–1543

    Article  CAS  PubMed  Google Scholar 

  • Perng CH, Chang YC, Tzang RF (2018) The treatment of cognitive dysfunction in dementia: a multiple treatments meta-analysis. Psychopharmacology 235:1571–1580

    Article  CAS  PubMed  Google Scholar 

  • Rancan L, Paredes SD, Garcia I, Munoz P, Garcia C, de Hontanar GL, de la Fuente M, Vara E, Tresguerres JAF (2017) Protective effect of xanthohumol against age-related brain damage. J Nutr Biochem 49:133–140

    Article  CAS  PubMed  Google Scholar 

  • Sarkaki A, Amani R, Badavi M, Safahani M, Aligholi H (2008) Effect of ovariectomy on reference memory version of Morris water maze in young adult rats. Iran Biomed J 12:123–128

    PubMed  Google Scholar 

  • Savonenko AV, Markowska AL (2003) The cognitive effects of ovariectomy and estrogen replacement are modulated by aging. Neuroscience 119:821–830

    Article  CAS  PubMed  Google Scholar 

  • Schliep KC, Barbeau WA, Lynch KE, Sorweid MK, Varner MW, Foster NL, Qeadan F (2022) Overall and sex-specific risk factors for subjective cognitive decline: findings from the 2015–2018 Behavioral Risk Factor Surveillance System Survey. Biol Sex Differ 13:16

    Article  PubMed  PubMed Central  Google Scholar 

  • Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498–2504

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Slawinska-Brych A, Zdzisinska B, Dmoszynska-Graniczka M, Jeleniewicz W, Kurzepa J, Gagos M, Stepulak A (2016) Xanthohumol inhibits the extracellular signal regulated kinase (ERK) signalling pathway and suppresses cell growth of lung adenocarcinoma cells. Toxicology 357–358:65–73

    Article  PubMed  Google Scholar 

  • Sun CJ, Liu JG, Duan F, Cong L, Qi XK (2022) The role of the microRNA regulatory network in Alzheimer’s disease: a bioinformatics analysis. Arch Med Sci 18:206–222

    CAS  PubMed  Google Scholar 

  • Tyagi R, Shenoy AR, Visweswariah SS (2009) Characterization of an evolutionarily conserved metallophosphoesterase that is expressed in the fetal brain and associated with the WAGR syndrome. J Biol Chem 284:5217–5228

    Article  CAS  PubMed  Google Scholar 

  • Vazquez-Cervantes GI, Ortega DR, Ayala TB, de la Cruz VP, Esquivel DFG, Salazar A, Pineda B (2021) Redox and anti-inflammatory properties from hop components in beer-related to neuroprotection. Nutrients 13:2000

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vedder LC, Bredemann TM, McMahon LL (2014) Estradiol replacement extends the window of opportunity for hippocampal function. Neurobiol Aging 35:2183–2192

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang H, Liu J, Zong Y, Xu Y, Deng W, Zhu H, Liu Y, Ma C, Huang L, Zhang L, Qin C (2010) miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer’s disease targets TGF-beta type II receptor. Brain Res 1357:166–174

    Article  CAS  PubMed  Google Scholar 

  • Wang L, Feng Z, Wang X, Wang X, Zhang X (2010) DEGseq: an R package for identifying differentially expressed genes from RNA-seq data. Bioinformatics 26:136–138

    Article  PubMed  Google Scholar 

  • Wang Y, Yang Z, Wang L, Sun L, Liu Z, Li Q, Yao B, Chen T, Wang C, Yang W, Liu Q, Han S (2019) miR-532-3p promotes hepatocellular carcinoma progression by targeting PTPRT. Biomed Pharmacother 109:991–999

    Article  CAS  PubMed  Google Scholar 

  • Zhang M, Ye Y, Cong J, Pu D, Liu J, Hu G, Wu J (2013) Regulation of STAT3 by miR-106a is linked to cognitive impairment in ovariectomized mice. Brain Res 1503:43–52

    Article  CAS  PubMed  Google Scholar 

  • Zhou Y, Zheng X, Lu J, Chen W, Li X, Zhao L (2018) Ginsenoside 20(S)-Rg3 inhibits the Warburg effect via modulating DNMT3A/ MiR-532-3p/HK2 pathway in ovarian cancer cells. Cell Physiol Biochem 45:2548–2559

    Article  CAS  PubMed  Google Scholar 

  • Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK (2019) Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun 10:1523

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This research was supported by the Special Foundation for Talents of Northwest A&F University (Z452017335).

Author information

Authors and Affiliations

Authors

Contributions

Wei Cao designed the study and wrote the paper; Yang Liu, Jiaxing Shao, Ruizhi Qiao, and Jiage Li provided technical support and obtained data; Yang Liu, Ruizhi Qiao, and Chenyu Li analyzed the data. Yang Liu, Jiaxing Shao, Ruizhi Qiao, and Wei Cao revised the manuscript.

Corresponding author

Correspondence to Wei Cao.

Ethics declarations

Ethics approval

All experimental procedures were approved by the Animal Care Commission of the College of Chemistry & Pharmacy, Northwest A&F University. All C57BL/6 J mice used in this study were purchased from the Experimental Animal Center of The Fourth Military Medical University (Xi’an, China). The mice were used for experiments at least 14 days after acclimatization to laboratory conditions and were maintained on a 12/12-h of light/dark cycle and 50–70% humidity with free access to food and water at the Laboratory Animal Facility of the College of Chemistry & Pharmacy, Northwest A&F University.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 452 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, Y., Shao, J., Qiao, R. et al. Xanthohumol improves cognitive impairment by regulating miRNA-532-3p/Mpped1 in ovariectomized mice. Psychopharmacology 240, 1169–1178 (2023). https://doi.org/10.1007/s00213-023-06355-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-023-06355-1

Keywords

Navigation